文献速递系统性红斑狼疮

BAFF中和治疗对系统性红斑狼疮相关动脉粥样硬化的影响

Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
PubMed 文献 · Arthritis Rheumatol · 2020-12-15

研究在动脉粥样硬化/狼疮易感ApoE敲除D227K小鼠模型及SLE患者队列中评估BAFF中和对SLE相关动脉粥样硬化的作用。抗BAFF单抗在低胆固醇小鼠中减轻病变(21%减少,P=0.007),在高胆固醇小鼠中病变加重(17%增加,P=0.06)。SLE患者血BAFF水平与亚临床动脉粥样硬化相关(r=0.26,P=0.03),抗BAFF治疗对颈动脉内膜中层厚度进展的影响因体重指数而异。

要点

  • 抗BAFF单抗在低胆固醇狼疮小鼠中减轻动脉粥样硬化病变,高胆固醇小鼠中则加重。
  • BAFF-BAFF受体与BAFF-TACI信号对动脉粥样硬化作用相反,前者保护后者促硬化。
  • SLE患者血BAFF水平与亚临床动脉粥样硬化相关,抗BAFF疗效受体重指数影响。

核心结论

  • 抗BAFF对SLE相关动脉粥样硬化的影响取决于脂质诱导与B细胞诱导的促动脉粥样硬化条件的平衡,可能有害也可能有益。

研究设计与样本

  • 研究在动脉粥样硬化/狼疮易感的载脂蛋白E敲除D227K小鼠模型中给予阻断性抗BAFF单克隆抗体并喂食标准饲料。
  • 同时在无心血管疾病症状的SLE患者队列中,用超声评估基线及随访期间颈动脉斑块和颈动脉内膜中层厚度。

主要发现

  • 抗BAFF单抗在ApoE-/- D227K小鼠中诱导B细胞耗竭、有效治疗狼疮,并使低血浆胆固醇小鼠的动脉粥样硬化病变减少21%(P=0.007)。
  • 抗BAFF单抗使高胆固醇小鼠的动脉粥样硬化病变增加17%(P=0.06)。
  • BAFF-BAFF受体信号抑制对B细胞的抗动脉粥样硬化作用被BAFF-TACI信号抑制对巨噬细胞的促动脉粥样硬化作用所抵消。
  • SLE患者血BAFF水平与亚临床动脉粥样硬化相关(r=0.26,P=0.03)。
  • 抗BAFF单抗治疗对SLE患者颈动脉内膜中层厚度进展的影响因体重指数不同而异。

临床怎么用

  • 在SLE患者中使用抗BAFF治疗时,需结合血脂水平和体重指数评估动脉粥样硬化风险。
  • 血BAFF水平或可作为SLE患者亚临床动脉粥样硬化的参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cardiovascular disease (CVD) is the leading cause of death in systemic lupus erythematosus (SLE). B cells play a key role in the pathogenesis of lupus, and anti-BAFF therapy has been approved for use in SLE. Since mature B cells also promote atherosclerosis, we undertook this study to evaluate, in a mouse model and in SLE patients, whether BAFF neutralization has an atheroprotective effect in SLE. METHODS: The effect of BAFF on atherosclerosis associated with lupus was investigated in the atherosclerosis/lupus-prone apolipoprotein E-knockout D227K mouse model and in a cohort of SLE patients. Mice were treated with a blocking anti-BAFF monoclonal antibody (mAb), while fed a standard chow diet. Carotid plaque and carotid intima-media thickness were assessed by ultrasound at baseline and during follow-up in SLE patients who were asymptomatic for CVD. RESULTS: Anti-BAFF mAb in ApoE-/- D227K mice induced B cell depletion, efficiently treated lupus, and improved atherosclerosis lesions (21% decrease; P = 0.007) in mice with low plasma cholesterol levels but worsened the lesions (17% increase; P = 0.06) in mice with high cholesterol levels. The atheroprotective effect of the BAFF-BAFF receptor signaling inhibition on B cells was counterbalanced by the proatherogenic effect of the BAFF-TACI signaling inhibition on macrophages. In SLE patients, blood BAFF levels were associated with subclinical atherosclerosis (r = 0.26, P = 0.03). Anti-BAFF mAb treatment had a differential effect on the intima-media thickness progression in SLE patients depending on body mass index. CONCLUSION: Depending on the balance between lipid-induced and B cell-induced proatherogenic conditions, anti-BAFF could be detrimental or beneficial, respectively, to atherosclerosis development in SLE.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Saidoune F, Even G, Lamri Y, et al. Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2020. PMID: 32783382. doi:10.1002/art.41485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。